• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Corneal descompensation in patients with endothelial compromise treated with topical dorzolamide].

作者信息

Domingo Gordo B, Urcelay Segura J L, Conejero Arroyo J, Balado Vázquez P, Rodríguez Ausín P

机构信息

Servicio de Oftalmología, Hospital General Universitario Gregorio Marañón, Madrid, España.

出版信息

Arch Soc Esp Oftalmol. 2002 Mar;77(3):139-44.

PMID:11967735
Abstract

PURPOSE

To investigate the possibility of corneal alterations in patients with long-term endothelial compromise with topical dorzolamide.

MATERIAL AND METHODS

Retrospective descriptive study of 17 patients with penetrating keratoplasty and glaucoma associated with topical carbonic anhydrase inhibitor therapy, looking for coincidence with corneal alteration.

RESULTS

Classified by ethiology, type of glaucoma and control, recording previous ophthalmological surgeries, evolution time, complications and rejection episodes. Seven patients suffered a corneal decompensation, in three of them there were signs of true reject but only four cases had edema at the beginning of dorzolamide treatment, one of them recovering after stopping dorzolamide. Risk factors were previous cataract surgery, mainly aphakia, filtering surgery and previous vitrectomy.

CONCLUSIONS

Dorzolamide could have a potential negative effect on patients with endothelial compromise.

摘要

相似文献

1
[Corneal descompensation in patients with endothelial compromise treated with topical dorzolamide].
Arch Soc Esp Oftalmol. 2002 Mar;77(3):139-44.
2
Inhibition of carbonic anhydrase activity in cultured bovine corneal endothelial cells by dorzolamide.多佐胺对培养的牛角膜内皮细胞碳酸酐酶活性的抑制作用。
Invest Ophthalmol Vis Sci. 2002 Oct;43(10):3273-8.
3
Switching from systemic to the topical carbonic anhydrase inhibitor dorzolamide: effect on the quality of life of glaucoma patients with drug-related side effects.从全身用碳酸酐酶抑制剂转为局部用多佐胺:对有药物相关副作用的青光眼患者生活质量的影响。
Isr Med Assoc J. 2003 Apr;5(4):260-3.
4
Irreversible corneal decompensation in patients treated with topical dorzolamide.使用局部多佐胺治疗的患者发生不可逆性角膜失代偿。
Am J Ophthalmol. 1999 Apr;127(4):403-6. doi: 10.1016/s0002-9394(98)00438-3.
5
Dorzolamide and corneal recovery from edema in patients with glaucoma or ocular hypertension.
Am J Ophthalmol. 2000 Feb;129(2):144-50. doi: 10.1016/s0002-9394(99)00274-3.
6
Short-term effect of topical dorzolamide hydrochloride on intrastromal corneal pressure in rabbit corneas in vivo.
Cornea. 2009 Feb;28(2):206-10. doi: 10.1097/ICO.0b013e318188ad80.
7
Effect of dorzolamide on corneal endothelial function in normal human eyes.多佐胺对正常人眼角膜内皮功能的影响。
Invest Ophthalmol Vis Sci. 1998 Jan;39(1):23-9.
8
Corneal endothelium and postoperative outcomes 15 years after penetrating keratoplasty.穿透性角膜移植术后15年的角膜内皮与术后结果
Am J Ophthalmol. 2005 Feb;139(2):311-9. doi: 10.1016/j.ajo.2004.09.045.
9
Short-term effect of dorzolamide hydrochloride on central corneal thickness in humans with cornea guttata.
Arch Ophthalmol. 2003 May;121(5):621-5. doi: 10.1001/archopht.121.5.621.
10
Experience with COSOPT, the fixed combination of timolol and dorzolamide, gained in Swiss ophthalmologists' offices.瑞士眼科医生诊所使用噻吗洛尔和多佐胺固定复方制剂COSOPT的经验。
Curr Med Res Opin. 2003;19(2):95-101. doi: 10.1185/030079902125001434.

引用本文的文献

1
Topical carbonic anhydrase inhibitors and glaucoma in 2021: where do we stand?2021年局部碳酸酐酶抑制剂与青光眼:我们目前的情况如何?
Br J Ophthalmol. 2022 Oct;106(10):1332-1337. doi: 10.1136/bjophthalmol-2021-319530. Epub 2021 Aug 25.
2
Ocular surface - a complex and vulnerable adoptive environment for topical glaucoma treatment.眼表——局部青光眼治疗的一个复杂且脆弱的适应性环境。
Rom J Ophthalmol. 2016 Jul-Sep;60(3):153-157.
3
Cornea and ocular surface disease: application of cutting-edge optometric research.角膜与眼表疾病:前沿验光研究的应用
Optom Vis Sci. 2014 Apr;91(4 Suppl 1):S3-16. doi: 10.1097/OPX.0000000000000226.
4
Effects of common topical antiglaucoma medications on the ocular surface, eyelids and periorbital tissue.常见局部抗青光眼药物对眼表面、眼睑和眼眶组织的影响。
Drugs Aging. 2011 Apr 1;28(4):267-82. doi: 10.2165/11588830-000000000-00000.
5
Knockdown of NBCe1 in vivo compromises the corneal endothelial pump.体内敲低NBCe1会损害角膜内皮泵功能。
Invest Ophthalmol Vis Sci. 2010 Oct;51(10):5190-7. doi: 10.1167/iovs.10-5257. Epub 2010 May 5.
6
Graft failure: III. Glaucoma escalation after penetrating keratoplasty.移植失败:III. 穿透性角膜移植术后青光眼病情进展
Int Ophthalmol. 2008 Jun;28(3):191-207. doi: 10.1007/s10792-008-9223-5.